Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Adrenal Gland Metastasis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT03155139
What this trial is testing

Primary Aldosteronism In Hypertensive Patients in China

Who this might be right for
Hyperaldosteronism; PrimaryHypertension Secondary
Qifu Li 3,500
Early research (Phase 1)Study completedNCT00005842
What this trial is testing

Trastuzumab Plus R115777 in Treating Patients With Advanced or Metastatic Cancer

Who this might be right for
Cancer
National Cancer Institute (NCI) 24
Testing effectiveness (Phase 2)Study completedNCT03008369
What this trial is testing

Lenvatinib in Treating Patients With Metastatic or Advanced Pheochromocytoma or Paraganglioma That Cannot Be Removed by Surgery

Who this might be right for
Malignant Adrenal Gland PheochromocytomaMalignant ParagangliomaMetastatic Adrenal Gland Pheochromocytoma
Mayo Clinic 3
Testing effectiveness (Phase 2)WithdrawnNCT04106843
What this trial is testing

Radioactive Drug (177Lu-DOTATATE) for the Treatment of Locally Advanced, Metastatic, or Unresectable Rare Endocrine Cancers

Who this might be right for
Locally Advanced Adrenal Gland PheochromocytomaLocally Advanced ParagangliomaMetastatic Adrenal Gland Pheochromocytoma+11 more
M.D. Anderson Cancer Center
Testing effectiveness (Phase 2)Study completedNCT01514526
What this trial is testing

Clinical Trial of Dovitinib in First-line Metastatic or Locally Advanced Non-resectable Adrenocortical Carcinoma

Who this might be right for
Adrenocortical Carcinoma
Spanish Oncology Genito-Urinary Group 17
Not applicableStudy completedNCT06664255
What this trial is testing

High Prevalence of Secondary Arterial Hypertension (HIPRESH) with Prospective Systematic Screening in a Cohort of Consecutive Hypertensive Patients Referring to Regional Specialized Center

Who this might be right for
HypertensionHypertension Resistant to Conventional TherapySecondary Hypertension to Endocrine Disorders+2 more
University Hospital Padova 1,400
Not applicableStudy completedNCT01185639
What this trial is testing

Stereotactic Body Radiation Therapy (SBRT) in Metastatic Non-small Cell Lung Cancer

Who this might be right for
Non-Small-Cell Lung CarcinomaLiver CancerAdrenal Cancer
Wake Forest University Health Sciences 29
Not applicableUnknownNCT06015061
What this trial is testing

Prediction and Evaluation of Anlotinib Treatment Response Using Contrast Enhanced Ultrasound PPGL Patients

Who this might be right for
Pheochromocytoma, MetastaticUltrasonographyParaganglioma, Malignant+1 more
Peking Union Medical College Hospital 20
Not applicableStudy completedNCT02938910
What this trial is testing

Study of Myocardial Interstitial Fibrosis in Hyperaldosteronism

Who this might be right for
Primary HyperaldosteronismSecondary HyperaldosteronismEssential Hypertension+1 more
Assistance Publique - Hôpitaux de Paris 80
Large-scale testing (Phase 3)Study completedNCT00924989
What this trial is testing

OSI-906 in Patients With Locally Advanced or Metastatic Adrenocortical Carcinoma

Who this might be right for
Adrenocortical Carcinoma
Astellas Pharma Inc 139
Early research (Phase 1)Study completedNCT02239900
What this trial is testing

Ipilimumab and Stereotactic Body Radiation Therapy (SBRT) in Advanced Solid Tumors

Who this might be right for
Liver CancerLung Cancer
M.D. Anderson Cancer Center 143
Testing effectiveness (Phase 2)Ended earlyNCT00947167
What this trial is testing

A Phase II Study of Pertuzumab and Erlotinib for Metastatic or Unresectable Neuroendocrine Tumors

Who this might be right for
Neuroendocrine TumorsCarcinoid TumorsAdrenal Gland Tumors+3 more
Pamela L. Kunz 4
Early research (Phase 1)Ended earlyNCT01832974
What this trial is testing

Possible New Therapy for Advanced Cancer

Who this might be right for
Adrenocortical Carcinoma
INSYS Therapeutics Inc 9
Not applicableUnknownNCT03896958
What this trial is testing

The PIONEER Initiative: Precision Insights On N-of-1 Ex Vivo Effectiveness Research Based on Individual Tumor Ownership (Precision Oncology)

Who this might be right for
Cancer, All TypesCancer of LiverCancer of Stomach+42 more
SpeciCare 1,000
Testing effectiveness (Phase 2)Ended earlyNCT04785287
What this trial is testing

Anti-CTLA4-NF mAb (BMS986218), Nivolumab, and Stereotactic Body Radiation Therapy for the Treatment of Metastatic Solid Malignancies

Who this might be right for
Advanced Lung CarcinomaAdvanced Malignant Solid NeoplasmMalignant Adrenal Gland Neoplasm+14 more
M.D. Anderson Cancer Center 13
Testing effectiveness (Phase 2)Study completedNCT05858177
What this trial is testing

The Efficacy and Safety of Temozolomide in Patients With MPPGL

Who this might be right for
Pheochromocytoma, MetastaticParaganglioma, MalignantPheochromocytoma Malignant
Peking Union Medical College Hospital 62
Testing effectiveness (Phase 2)Looking for participantsNCT06587802
What this trial is testing

Phase II Study of PD-1 Antibody Combined With Radiotherapy in Recurrent or Metastatic Adrenal Cortical Carcinoma

Who this might be right for
Adrenocortical Carcinoma
Sun Yat-sen University 18
Not applicableStudy completedNCT03105531
What this trial is testing

Screening for Primary Aldosteronism in a Population of Patients With Hypertension

Who this might be right for
Primary AldosteronismHypertensionHypertension Secondary
Uppsala University 1,183
Very early researchStudy completedNCT00436410
What this trial is testing

Tumor Necrosis Factor in Patients Undergoing Surgery for Primary Cancer or Metastatic Cancer

Who this might be right for
Adrenocortical CarcinomaBreast CancerColorectal Cancer+7 more
National Institutes of Health Clinical Center (CC) 108
Early research (Phase 1)Ended earlyNCT03145909
What this trial is testing

A Study Evaluating the Safety, Pharmacokinetics and Anti-Tumor Activity of ABBV-176 in Subjects With Advanced Solid Tumors Likely to Express Prolactin Receptor (PRLR)

Who this might be right for
Advanced Solid Tumors Cancer
AbbVie 19
Next Page